How can Aledade improve its population health management tools to better identify high-risk patients?

Introduction

To improve Aledade's population health management tools for better identification of high-risk patients, we need to analyze the current system, understand user needs, and develop targeted solutions. I'll approach this by examining key stakeholders, analyzing pain points, generating solutions, and proposing metrics for success.

Step 1

Clarifying Questions (5 mins)

• Looking at Aledade's position in the healthcare technology market, I'm curious about the primary users of our population health management tools. Could you clarify if we're primarily serving healthcare providers, payers, or both?

Why it matters: This will help us tailor our solutions to the specific needs and workflows of our main user base. Expected answer: Primarily serving healthcare providers (e.g., primary care physicians, care coordinators) Impact on approach: Would focus on integrating with clinical workflows and EHR systems

• Considering the evolving landscape of value-based care, I'm wondering about our current data sources for patient risk stratification. Can you share what types of data we're currently using and if there are any limitations or gaps?

Why it matters: Identifies potential areas for improvement in our risk identification algorithms Expected answer: Currently using claims data, some EHR data, but limited social determinants of health (SDOH) data Impact on approach: Would explore ways to incorporate more diverse data sources, especially SDOH

• Given the critical nature of identifying high-risk patients, I'm interested in understanding our current performance metrics. What's our current accuracy rate in identifying high-risk patients, and how does it compare to industry benchmarks?

Why it matters: Establishes a baseline for improvement and helps set realistic goals Expected answer: Current accuracy rate around 70-75%, slightly below industry leaders at 80-85% Impact on approach: Would focus on significant accuracy improvements to match or exceed industry leaders

• Considering the rapid advancements in AI and machine learning, I'm curious about our current use of these technologies. To what extent are we leveraging AI/ML in our risk stratification models?

Why it matters: Determines if there's untapped potential in advanced analytics for risk identification Expected answer: Basic machine learning models in use, but not leveraging latest AI advancements Impact on approach: Would explore integrating more advanced AI/ML techniques to enhance predictive capabilities